- Executive Summary
- Global Pharmaceutical Drug Development Services Market Introduction
2.1. Global Pharmaceutical Drug Development Services Market – Taxonomy
2.2. Global Pharmaceutical Drug Development Services Market –Definitions
2.2.1. By Molecule
2.2.2. By Phase
2.2.3. By Specialty Type
- Global Pharmaceutical Drug Development Services Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Pharmaceutical Drug Development Services Market Dynamics – Factors Impact Analysis
- Global Pharmaceutical Drug Development Services Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
4.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
- Global Pharmaceutical Drug Development Services Market Forecast, By Molecule, 2014 - 2018 and Forecast, 2019 - 2025
5.1. Biologic Solutions
5.1.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Small Molecule Solutions
5.2.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Biosimilar Development Solutions
5.3.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
- Global Pharmaceutical Drug Development Services Market Forecast, By Phase, 2014 - 2018 and Forecast, 2019 - 2025
6.1. Pre-Clinical
6.1.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Phase 1
6.2.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Phase II
6.3.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Phase III
6.4.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
- Global Pharmaceutical Drug Development Services Market Forecast, By Specialty Type, 2014 - 2018 and Forecast, 2019 - 2025
7.1. Cardiovascular
7.1.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Diabetes, Endocrinology, and Nephrology
7.2.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Immuno-Oncology
7.3.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Infectious Diseases
7.4.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Oncology
7.5.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Rare Diseases and Orphan Drugs
7.6.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn)
7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.6.3. Market Opportunity Analysis
7.7. Pediatrics
7.7.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn)
7.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.7.3. Market Opportunity Analysis
7.8. Neuroscience
7.8.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn)
7.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.8.3. Market Opportunity Analysis
7.9. Others
7.9.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn)
7.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.9.3. Market Opportunity Analysis
- Global Pharmaceutical Drug Development Services Market Forecast, By Region, 2014 - 2018 and Forecast, 2019 - 2025
8.1. North America
8.1.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia Pacific
8.3.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. The Middle East & Africa
8.5.1. Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Pharmaceutical Drug Development Services Market - Opportunity Analysis Index, By Product, By Application, By End User, and Region, 2019 - 2025
- North America Pharmaceutical Drug Development Services Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
9.1. Molecule Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Biologic Solutions
9.1.2. Small Molecule Solutions
9.1.3. Biosimilar Development Solutions
9.2. Phase Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.2.1. Pre-Clinical
9.2.2. Phase I
9.2.3. Phase II
9.2.4. Phase III
9.3. Specialty Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.3.1. Cardiovascular
9.3.2. Diabetes, Endocrinology, and Nephrology
9.3.3. Immuno-Oncology
9.3.4. Infectious Diseases
9.3.5. Oncology
9.3.6. Rare Diseases and Orphan Drugs
9.3.7. Pediatrics
9.3.8. Neuroscience
9.3.9. Others
9.4. Country Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. U.S.
9.4.2. Canada
9.5. North America Pharmaceutical Drug Development Services Market - Opportunity Analysis Index, By Molecule Type, By Phase, By Specialty Type, and Country, 2019 - 2025
9.6. North America Pharmaceutical Drug Development Services Market Dynamics – Trends
- Europe Pharmaceutical Drug Development Services Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
10.1. Molecule Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Biologic Solutions
10.1.2. Small Molecule Solutions
10.1.3. Biosimilar Development Solutions
10.2. Phase Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Pre-Clinical
10.2.2. Phase I
10.2.3. Phase II
10.2.4. Phase III
10.3. Specialty Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.3.1. Cardiovascular
10.3.2. Diabetes, Endocrinology, and Nephrology
10.3.3. Immuno-Oncology
10.3.4. Infectious Diseases
10.3.5. Oncology
10.3.6. Rare Diseases and Orphan Drugs
10.3.7. Pediatrics
10.3.8. Neuroscience
10.3.9. Others
10.4. Country Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. U.K.
10.4.2. Germany
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Russia
10.4.7. Rest of Europe
10.5. Europe Pharmaceutical Drug Development Services Market - Opportunity Analysis Index, By Molecule, By Phase, By Specialty Type, and Country, 2019 - 2025
10.6. Europe Pharmaceutical Drug Development Services Market Dynamics – Trends
- Asia Pacific Pharmaceutical Drug Development Services Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
11.1. Molecule Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Biologic Solutions
11.1.2. Small Molecule Solutions
11.1.3. Biosimilar Development Solutions
11.2. Phase Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Pre-Clinical
11.2.2. Phase I
11.2.3. Phase II
11.2.4. Phase III
11.3. Specialty Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.3.1. Cardiovascular
11.3.2. Diabetes, Endocrinology, and Nephrology
11.3.3. Immuno-Oncology
11.3.4. Infectious Diseases
11.3.5. Oncology
11.3.6. Rare Diseases and Orphan Drugs
11.3.7. Pediatrics
11.3.8. Neuroscience
11.3.9. Others
11.4. Country Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. ASEAN Counties
11.4.5. Philippines
11.4.6. Rest of Asia Pacific
11.5. Asia Pacific Pharmaceutical Drug Development Services Market - Opportunity Analysis Index, By Molecule, By Phase, By Specialty Type, and Country, 2019 - 2025
11.6. Asia Pacific Pharmaceutical Drug Development Services Market Dynamics – Trends
- Latin America Pharmaceutical Drug Development Services Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
12.1. Molecule Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Biologic Solutions
12.1.2. Small Molecule Solutions
12.1.3. Biosimilar Development Solutions
12.2. Phase Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Pre-Clinical
12.2.2. Phase I
12.2.3. Phase II
12.2.4. Phase III
12.3. Specialty Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Cardiovascular
12.3.2. Diabetes, Endocrinology, and Nephrology
12.3.3. Immuno-Oncology
12.3.4. Infectious Diseases
12.3.5. Oncology
12.3.6. Rare Diseases and Orphan Drugs
12.3.7. Pediatrics
12.3.8. Neuroscience
12.3.9. Others
12.4. Country Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Mexico
12.4.2. Brazil
12.4.3. Argentina
12.4.4. Chile
12.4.5. Rest of Latin America
12.5. Latin America Pharmaceutical Drug Development Services Market - Opportunity Analysis Index, By Molecule, By Phase, By Specialty Type, and Country, 2019 - 2025
12.6. Latin America Pharmaceutical Drug Development Services Market Dynamics – Trends
- Middle East and Africa Pharmaceutical Drug Development Services Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
13.1. Molecule Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Biologic Solutions
13.1.2. Small Molecule Solutions
13.1.3. Biosimilar Development Solutions
13.2. Phase Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Pre-Clinical
13.2.2. Phase I
13.2.3. Phase II
13.2.4. Phase III
13.3. Specialty Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.3.1. Cardiovascular
13.3.2. Diabetes, Endocrinology, and Nephrology
13.3.3. Immuno-Oncology
13.3.4. Infectious Diseases
13.3.5. Oncology
13.3.6. Rare Diseases and Orphan Drugs
13.3.7. Pediatrics
13.3.8. Neuroscience
13.3.9. Others
13.4. Country Analysis (2014 - 2018) and Forecast (2019 - 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Saudi Arabia
13.4.4. Turkey
13.4.5. Rest of MEA
13.5. Middle East and Africa Pharmaceutical Drug Development Services Market - Opportunity Analysis Index, By Molecule, By Phase, By Specialty Type, and Country, 2019 - 2025
13.6. Middle East and Africa Pharmaceutical Drug Development Services Market Dynamics – Trends
- Competition Landscape
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Syneos Health
14.2.2. Parexel
14.2.3. IQVIA
14.2.4. Celerion
14.2.5. Piramal Pharma solutions
14.2.6. Catalent, Inc.
14.2.7. Patheon - a Thermo Fisher Company
14.2.8. Pharmaceutical Product Development, LLC.
14.2.9. Covance Inc.
14.2.10. MEDPACE
- Research Methodology
- Key Assumptions and Acronyms